Literature DB >> 24599885

Scorpion venoms as a potential source of novel cancer therapeutic compounds.

Jian Ding1, Pei-Jou Chua, Boon-Huat Bay, P Gopalakrishnakone.   

Abstract

Scorpions and their venoms have been used in traditional medicine for thousands of years in China, India and Africa. The scorpion venom is a highly complex mixture of salts, nucleotides, biogenic amines, enzymes, mucoproteins, as well as peptides and proteins (e.g. neurotoxins). One of the recently observed biological properties of animal venoms and toxins is that they possess anticancer potential. An increasing number of studies have shown that scorpion venoms and toxins can decrease cancer growth, induce apoptosis and inhibit cancer progression and metastasis in vitro and in vivo. Several active molecules with anticancer activities, ranging from inhibition of proliferation and cell cycle arrest to induction of apoptosis and decreasing cell migration and invasion, have been isolated from scorpion venoms. These observations have shed light on the application of scorpion venoms and toxins as potential novel cancer therapeutics. This mini-review focuses on the anticancer potential of scorpion venoms and toxins and the possible mechanisms for their antitumor activities.

Entities:  

Keywords:  Scorpion; anticancer potential; apoptosis; venoms and toxins

Mesh:

Substances:

Year:  2014        PMID: 24599885     DOI: 10.1177/1535370213513991

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  31 in total

1.  SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin.

Authors:  Wenli Qiao; Lingzhou Zhao; Shan Wu; Changcun Liu; Lilei Guo; Yan Xing; Jinhua Zhao
Journal:  J Neurooncol       Date:  2017-05-09       Impact factor: 4.130

Review 2.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

3.  In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines.

Authors:  Abdulrahman Khazim Al-Asmari; Mozaffarul Islam; Ali Mater Al-Zahrani
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

4.  Evaluation of in vivo Lethality and in vitro Cytotoxic Effect of Odontobuthus bidentatus Scorpion Venom.

Authors:  Z Salehi-Najafabadi; H R Goudarzi; M Sajadi
Journal:  Arch Razi Inst       Date:  2022-02-28

5.  A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.

Authors:  Xiufeng Liu; Xintong Liu; Suwen Sunchen; Meixia Liu; Chen Shen; Juanjuan Wu; Wanli Zhao; Boyang Yu; Jihua Liu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.

Authors:  Chao Zhang; Xinlong He; Yaping Gu; Huayun Zhou; Jun Cao; Qi Gao
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

7.  Pathogen-inspired drug delivery to the central nervous system.

Authors:  Rebecca L McCall; Joseph Cacaccio; Eileen Wrabel; Mary E Schwartz; Timothy P Coleman; Rachael W Sirianni
Journal:  Tissue Barriers       Date:  2014-08-08

8.  In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model.

Authors:  Mohamed L Salem; Nahla M Shoukry; Wafaa K Teleb; Mohamed M Abdel-Daim; Mohamed A Abdel-Rahman
Journal:  Springerplus       Date:  2016-05-10

9.  Enzymatic analysis of venom from Cuban scorpion Rhopalurus junceus.

Authors:  Alexis Díaz-García; Jenny Laura Ruiz-Fuentes; Arianna Yglesias-Rivera; Hermis Rodríguez-Sánchez; Yanelis Riquenes Garlobo; Osmel Fleitas Martinez; José A Fraga Castro
Journal:  J Venom Res       Date:  2015-07-22

10.  VenomKB, a new knowledge base for facilitating the validation of putative venom therapies.

Authors:  Joseph D Romano; Nicholas P Tatonetti
Journal:  Sci Data       Date:  2015-11-24       Impact factor: 6.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.